Magnusiomyces capitatus: a new and emerging pathogen linked to keratomycosis
Author(s) -
Ankit Shah,
Thomas F. Mauger
Publication year - 2017
Publication title -
digital journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.223
H-Index - 7
ISSN - 1542-8958
DOI - 10.5693/djo.02.2017.04.001
Subject(s) - voriconazole , natamycin , amphotericin b , medicine , fungal keratitis , antibiotics , keratitis , microbiology and biotechnology , dermatology , biology , antifungal , pathology
We describe our experience managing a case of fungal keratitis in a 71-year-old immunocompetent woman. Intracameral cultures isolated Magnusiomyces capitatus , a dimorphic commensal microbe with limited pathogenicity, in an immune competent patient. Repeated corneal cultures for bacteria and fungus were negative. Initial broad-spectrum topical fortified antibiotics were eventually escalated to include topical natamycin and voriconazole and oral voriconazole. The patient underwent emergent corneal transplantation, but recurrent infection eventually required anterior chamber washout and intracameral injection of amphotericin B. A combination of topical, systemic, intracameral administration of voriconazole, intracameral administration of amphotericin B, anterior chamber washout, and penetrating keratoplasty were required to clear the infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom